Running Oak Capital’s Boston Scientific BSX Stock Holding History

Running Oak Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,986	Closed	-$213K	–	56
2025 Q2	$213K	Sell	1,986 -268	-12%	-$27.1K	0.02%	56
2025 Q1	$227K	Sell	2,254 -169,085	-99%	-$17M	0.03%	56
2024 Q4	$15.3M	Buy	171,339 +8,018	+5%	+$706K	2%	6
2024 Q3	$13.7M	Buy	163,321 +3,653	+2%	+$288K	1.85%	16
2024 Q2	$12.3M	Sell	159,668 -7,841	-5%	-$574K	1.91%	7
2024 Q1	$11.5M	Buy	167,509 +13,634	+9%	+$877K	1.84%	20
2023 Q4	$8.9M	Buy	153,875 +23,091	+18%	+$1.23M	1.75%	36
2023 Q3	$6.91M	Buy	130,784 +1,717	+1%	+$90K	1.77%	32
2023 Q2	$6.98M	Buy	+129,067	New	+$6.74M	1.71%	40

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Running Oak Capital's BSX Position: Q3 2025 in Review

Running Oak Capital sold out of Boston Scientific (BSX) in Q3 2025, closing a stake of 1,986 shares — an estimated $213K sold.

Running Oak Capital first reported a position in BSX in Q2 2023 and held it in 9 quarters. The position peaked at $15.3M in Q4 2024. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

Running Oak Capital reported no remaining Boston Scientific position as of Q3 2025 after selling out during the quarter.
Running Oak Capital sold 1,986 Boston Scientific shares in Q3 2025, an estimated $213K.
Running Oak Capital first reported a position in Boston Scientific in Q2 2023 and held it in 9 quarters.
Running Oak Capital's Boston Scientific position peaked at $15.3M in Q4 2024.
1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Running Oak Capital's 13F filing for Q3 2025, filed 4 Nov 2025.